Birdwatch Note
2021-09-03 03:02:11 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
"Ivermectin continues to offer new clinical applications due to its ability to be repurposed to treat new classes of diseases. an increasing body of evidence points to the potential of ivermectin as an antiviral agent." https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539925/
Written by 580C19BF81D45F7D37B6E9F67318218F
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1433189523698114567
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1433626348568854531
- noteId - 1433626348568854531
- participantId - 580C19BF81D45F7D37B6E9F67318218F
- noteAuthorParticipantId -
- createdAtMillis - 1630638131658
- tweetId - 1433189523698114567
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable - BELIEVABLE_BY_MANY
- harmful - CONSIDERABLE_HARM
- validationDifficulty - EASY
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- "Ivermectin continues to offer new clinical applications due to its ability to be repurposed to treat new classes of diseases. an increasing body of evidence points to the potential of ivermectin as an antiviral agent." https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7539925/
Note Status History
createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
2021-09-03 03:02:11 UTC (1630638131658) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
29DA6110A61CBE04D190689E96385E47A0585048E715863A0572B02EBE9890DF | ||
2021-09-03 03:02:11 UTC (1630638131658) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
580C19BF81D45F7D37B6E9F67318218F |
Note Ratings
rated at | rated by | |
2021-09-03 08:31:37 -0500 | 038D3CEB938B58575E97A29178D65F43D226F536986BCB865DC5247B8034D04F | Rating Details |
2021-09-03 12:25:05 -0500 | 0C904048DFD99ECD7D3DF725D60CC661 | Rating Details |
2021-09-03 07:42:59 -0500 | 124DECA39D89D96FC1A851221A33A7A78A17B32320F6492A5CC36B63025D4A3D | Rating Details |
2021-09-04 21:43:07 -0500 | 157996AEE74DEA025123556C6A85957B77CCDB3D7CC7205A58B257863E374906 | Rating Details |
2021-09-03 05:51:50 -0500 | 22BD90261C6AD4F1761419CB62446BE0 | Rating Details |
2021-09-02 22:44:45 -0500 | 238938F8A35959DAFA9518817DEB65AA | Rating Details |
2021-09-03 00:01:16 -0500 | 26406325DB90AA12567D8E23C9031135 | Rating Details |
2021-09-03 00:01:16 -0500 | 2AEA5110D61205F1D34ADB3324F7177E5E7AA4662B263189D9051F65086CD8D6 | Rating Details |
2021-09-03 07:48:12 -0500 | 2CC2DBECB17C9BC94D21D3EDC785586BDD1B2F579218C4DD0CA0F36A3062070E | Rating Details |
2021-09-02 23:35:56 -0500 | 2CF95DC98CFBD39FC9C1B16D7A52C2B7EB376D63C077D0B9E03A238420EF00BF | Rating Details |
2021-09-03 08:41:47 -0500 | 2E2477629A5FC07DD87799E8F2C03003 | Rating Details |
2021-09-03 08:31:37 -0500 | 319DC899E23BD57088D7BEB822C7DA96 | Rating Details |
2021-09-03 10:27:32 -0500 | 3374CDDB8749AD331F74796AC9D150A6D9F2ADFF2EC515098F3F269B9B590B2A | Rating Details |
2021-09-03 05:22:29 -0500 | 35821F30BAE5462204CAEDE7B877DFBA | Rating Details |
2021-09-03 14:25:10 -0500 | 36791A2E4CE37B91D143D876A6EB438E27DB27E82D922E6307AED12C491A9996 | Rating Details |
2021-09-02 23:21:29 -0500 | 38D6E46624CE956827B6CDF21C7E56B075BC3BE4883B190B6FB7F2E429B435F9 | Rating Details |
2021-09-03 18:12:50 -0500 | 3C167E87653302C0C09B72A0A4BE89BDA2C58A5984188A7080B2712DCF482019 | Rating Details |
2021-09-03 17:16:22 -0500 | 3D8937C8D4CA66F90A71B6441E253133F637D96FB749C3ACDFEF6E8B1BBA8E14 | Rating Details |
2021-09-04 19:59:14 -0500 | 3E5BEEB710F714D0E38B3CCC9B47D610 | Rating Details |
2021-09-03 14:11:55 -0500 | 4670B97EA47BEFD25C935283AEAA64AA | Rating Details |
2021-09-02 23:12:53 -0500 | 47AD3BD4ED0E64C9EA74DB3A322FA6AA5E5F8D84E57A6E405CC624F53C571EC8 | Rating Details |
2021-09-02 23:35:56 -0500 | 47C5A1192E423563929A96EC1C8AEE27 | Rating Details |
2021-09-03 08:59:12 -0500 | 4E364FDA78DFC0FD908FC605C5E122964B5B38DF623C46107840C4C272D2E6B7 | Rating Details |
2021-09-03 07:48:12 -0500 | 51C9ED09516AFB774B6DA6B6BDCF27B2 | Rating Details |
2021-09-03 14:25:10 -0500 | 534CF19B708A912EC8975028BD9DA978 | Rating Details |
2021-09-03 07:42:59 -0500 | 5B5B064A289F60BE42D4461AB3A55FF0 | Rating Details |
2021-09-03 07:54:30 -0500 | 62CA38EE94AC8F23D0B4F3ED5AD6CB079C7A0C68FD9C03CB17ABD72835B67032 | Rating Details |
2021-09-03 10:27:32 -0500 | 6A7182B94B9A5134B37AF9841F0F979B | Rating Details |
2021-09-03 07:19:57 -0500 | 6D2D1366C9E38491A0E314EE0D24AFE0 | Rating Details |
2021-09-03 08:41:47 -0500 | 6E4FAF127C5C4B87087A7221C04DEA7CEC4D36AC5E95D8D766EDF0CB2FDDD43B | Rating Details |
2021-09-02 23:21:29 -0500 | 72248155A864C4A33B20212DF07B9A43 | Rating Details |
2021-09-03 01:35:14 -0500 | 788C6C5962BEB66E59FE179F6B6F7A74E21FD82608D26EE0E82CE0E38F4C18CD | Rating Details |
2021-09-03 09:18:48 -0500 | 8052B3126D9744C5D8B97881F9FE4C53 | Rating Details |
2021-09-05 11:05:17 -0500 | 807F2AC602D88D8AA16A9D051E850486 | Rating Details |
2021-09-03 01:35:14 -0500 | 82067FF361D981AB4A5E52136CAB70F7 | Rating Details |
2021-09-03 07:31:56 -0500 | 832EF93BF5C58C57F1E80BDF11CEE5CE | Rating Details |
2021-09-03 17:16:22 -0500 | 86D87C6A32C0F45008E1704F32AD4BE3 | Rating Details |
2021-09-05 11:05:17 -0500 | 8BF61FE49D2F6CAF1D17BF448F444DCD09E9B31C5418D7158A95100BE6980751 | Rating Details |
2021-09-03 07:31:56 -0500 | 9616DC0FFC401D0AA2A8EB445C1DA1EBB511EB6024619C0FE5F1DF87D79F36FB | Rating Details |
2021-09-02 22:44:45 -0500 | 9736DF42171A999208E640D9616E3AF1D2219C9694E38F806D374F891F58485E | Rating Details |
2021-09-03 06:50:34 -0500 | 975236A4E88159934D823A96DD27D6D6 | Rating Details |
2021-09-02 23:12:53 -0500 | 9795BF8962792425EFA8D2F4F92685B4 | Rating Details |
2021-09-03 14:11:55 -0500 | 97DC9F6D7011A19E8190EB5803F28D4CF6A83C54152E319583D633AB967E916A | Rating Details |
2021-09-03 06:37:56 -0500 | 99C9E6DE2BA16D23C320C1879BDDEE7DEA7686BE2B3B0C6B5AC5DD524EDA5D44 | Rating Details |
2021-09-03 07:19:57 -0500 | A677CA81007198D6ABE48598355CAC9B7FFC4C6C46A46FD139699ECF65D3E6CA | Rating Details |
2021-09-03 09:18:48 -0500 | B36992DC652FBD7E01FEF5C02B449D71BCA533C16F5CFC07266C2BC708965465 | Rating Details |
2021-09-03 05:22:29 -0500 | B3FF6118BA1CAD001AF90ADEE2AFC2DFFF5D2028EDBEEBFE81BBACC503F0477A | Rating Details |
2021-09-03 00:45:17 -0500 | B4202B168C177995846CB7DEBBD39A52B07EB8A28582ADEE3AB863B411E53FB2 | Rating Details |
2021-09-03 06:37:56 -0500 | B615F49A9CD7F18B52DAE3F567FEAA3D | Rating Details |
2021-09-04 21:43:07 -0500 | C4C47C5E9D82B35E21672D1C91A3C2B4 | Rating Details |
2021-09-03 00:45:17 -0500 | D5B37C16CDE52C84DE4907830A52DA3F | Rating Details |
2021-09-03 07:54:30 -0500 | D9D6381D990A005CE585D0A306B35233 | Rating Details |
2021-09-04 19:59:14 -0500 | E1207B187EE74B5A470FF9DEDE182B6DB94A359F02214BD8A4A8F04F27BC9421 | Rating Details |
2021-09-03 12:25:05 -0500 | E7FC9FC01B2849BEAE6E045B1B8BC1C71B88879FD355478E27AEE8E70049A28E | Rating Details |
2021-09-03 06:50:34 -0500 | E9BD54B366D4926C7634CBA8916803085D6E3D1DAEAF0EE6E8FCF1D730A65A01 | Rating Details |
2021-09-03 08:59:12 -0500 | F2835CA0B6611E1B4BB2761F48C4DD1B | Rating Details |
2021-09-03 05:51:50 -0500 | FA8782589D5C0955E88352515EF2408BFF8FD7DDE6D04B7D00F015C099A3384E | Rating Details |
2021-09-03 18:12:50 -0500 | FB8ABDC9C9B909F4C4F4797C55D30838 | Rating Details |
2021-09-04 19:59:14 -0500 | Rating Details | |
2021-09-03 05:22:29 -0500 | Rating Details | |
2021-09-05 11:05:17 -0500 | Rating Details | |
2021-09-03 05:51:50 -0500 | Rating Details | |
2021-09-03 06:50:34 -0500 | Rating Details | |
2021-09-03 08:31:37 -0500 | Rating Details | |
2021-09-04 21:43:07 -0500 | Rating Details | |
2021-09-03 01:35:14 -0500 | Rating Details | |
2021-09-02 22:44:45 -0500 | Rating Details | |
2021-09-03 00:01:16 -0500 | Rating Details | |
2021-09-03 08:41:47 -0500 | Rating Details | |
2021-09-03 07:48:12 -0500 | Rating Details | |
2021-09-03 00:45:17 -0500 | Rating Details | |
2021-09-03 18:12:50 -0500 | Rating Details | |
2021-09-03 14:25:10 -0500 | Rating Details | |
2021-09-03 07:19:57 -0500 | Rating Details | |
2021-09-03 07:31:56 -0500 | Rating Details | |
2021-09-03 10:27:32 -0500 | Rating Details | |
2021-09-02 23:21:29 -0500 | Rating Details | |
2021-09-03 09:18:48 -0500 | Rating Details | |
2021-09-03 08:59:12 -0500 | Rating Details | |
2021-09-03 17:16:22 -0500 | Rating Details | |
2021-09-03 07:54:30 -0500 | Rating Details | |
2021-09-03 14:11:55 -0500 | Rating Details | |
2021-09-03 07:42:59 -0500 | Rating Details | |
2021-09-03 12:25:05 -0500 | Rating Details | |
2021-09-02 23:35:56 -0500 | Rating Details | |
2021-09-03 06:37:56 -0500 | Rating Details | |
2021-09-02 23:12:53 -0500 | Rating Details |